Tech Company Financing Transactions
CiVi Biopharma Funding Round
Private investors joined a $49 million funding round for CiVi Biopharma. The round was announced on 5/23/2018.
Transaction Overview
Company Name
Announced On
5/23/2018
Transaction Type
Venture Equity
Amount
$49,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 6 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5425 Wisconsin Ave. 6th Floor
Chevy Chase, MD 20815
USA
Chevy Chase, MD 20815
USA
Phone
Website
Email Address
Overview
CiVi Biopharma Inc. is a US-based, privately held biopharmaceutical company, founded in 2016. The company's research and development activities are focused on creating novel therapies against cardiovascular and metabolic diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Shal Jacobovitz
Chief Scientific Officer
Henrik Ørum
VP - Bus. Development
Chuck Shear
Browse more venture capital transactions:
Prev: 5/23/2018: ValiMail venture capital transaction
Next: 5/23/2018: Phenom People venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs